Life Sciences banner

LIFE SCIENCES AND BIOTECH
INDUSTRIES

Kevin Sarney

Your Trusted Life Sciences Fractional CFO and Practice Leader


Kevin Sarney serves as a life science CFO for our clients. He has over 20 years of experience in public and private life science companies. His life science financial consulting expertise can help your organization prepare for and complete financial raises, financial controls, audits, SEC reports, and more. Kevin will be there to support your financial operations, from drug developments all the way to product launches. 

 

Kevin's wealth of knowledge and expertise has allowed Tsaro, Genocea, Enumeral, and a number of other companies to go public. He is a CPA with an MBA from Boston University, an M.A. in accounting from Suffolk University, and a B.S. in management from the University of Hartford.

Life Sciences

We are pleased to partner with executives and finance teams in the life science industry including biotech, pharma and medtech. Time after time, clients rely on our fractional and interim life science CFO and outsourced accounting services to:
 

  • Reduce costs

  • Take advantage of specialized knowledge and training

  • Eliminate the need for headcount expansion during critical growth stages, from pre-funded start-up to post-IPO

 

Our life sciences financial consulting service can help you address a variety of common challenges including labor-intensive budgeting, multiple scenario planning, long-term project R&D cycles, and capital-intensive planning.

RECENT ARTICLE

life sciences connect with us

TRUSTED
SMART
LEADERS

“We outsourced our complete accounting and finance function for the life of our biotech company, from inception to even after we were acquired by Celgene. Charles River CFO provided exceptional service throughout – outsourcing accounting and finance was a successful solution for us.”

 

Jay Mohr
Founder, and former CEO
Gloucester Pharmaceuticals

gloucester.png

"I have worked with Charles River CFO on two business.  Very happy with our relationship with them. 


Rick Pierce
CEO & Cofounder
SanaRx Biotherapeutics, Inc. / Decoy Therapeutics

decoy2.png